steady state [npop]
Pharmacokinetics [phsf]
gabapentin [orch, phsu]
Administration [ocac]
Novel [tmco]
Extended Release [bodm]
Formulation [resa]
postmenopausal [tmco]
Women [popg]
vasomotor symptom [sosy]
Objective [inpr]
Approximately [qlco]
postmenopausal [tmco]
Women [popg]
experience [menp]
vasomotor symptom [sosy]
Hot Flashes [sosy]
Currently [tmco]
Hormone replacement therapy [topp]
Approved [qlco]
treatment [ftcn]
Hot Flashes [sosy]
Increased [qnco]
Invasive Breast Cancer [neop]
coronary heart disease [dsyn]
Stroke [dsyn]
Venous thromboembolic disease [patf]
gabapentin [orch, phsu]
Efficacy [qlco]
treatment [ftcn]
vasomotor symptom [sosy]
postmenopausal [tmco]
Women [popg]
Administered [ftcn]
times [tmco]
Extended Release [bodm]
Formulation [resa]
gabapentin [orch, phsu]
gabapentin [orch, phsu]
Recently [tmco]
Efficacy [qlco]
treatment [ftcn]
postmenopausal [tmco]
Hot Flashes [sosy]
Objective [inpr]
Paper [mnob]
Report [inpr]
steady state [npop]
Pharmacokinetics [phsf]
Safety [hcpp]
gabapentin [orch, phsu]
Dose Regimen [topp]
gabapentin [orch, phsu]
postmenopausal [tmco]
Women [popg]
Hot Flashes [sosy]
Methods [inpr]
randomized [resa]
DOUBLE BLIND [resa]
Dose [qnco]
placebo-controlled [resa]
Parallel Study [resa]
Group [idcn]
postmenopausal [tmco]
Women [popg]
experience [menp]
Moderate [qlco]
Severe [qlco]
Hot Flashes [sosy]
Study [mnob]
treatment [ftcn]
preceded [tmco]
Titration [lbpr]
Assigned [ftcn]
Dose [qnco]
Group [idcn]
Received [qlco]
gabapentin 600 MG [clnd]
Evening [tmco]
PM [tmco]
mg% [qnco]
Morning [tmco]
mg% [qnco]
mg% [qnco]
Then [tmco]
mg% [qnco]
mg/mg [qnco]
PM [tmco]
mg% [qnco]
mg% [qnco]
mg% [qnco]
Second [qnco]
Tablets [bodm]
Taken [cnce]
Non-specified [qlco]
Meal [dora]
PHARMACOKINETIC [resa]
Sampling [diap]
Conduct [inbe]
Hour [tmco]
End [spco]
Study [mnob]
Plasma sample [bdsu]
Liquid Chromatography Mass Spectrometry [lbpr]
TANDEM [orch, phsu]
Compartment [bsoj]
PHARMACOKINETIC [resa]
Performed [ftcn]
Concentration [menp]
Area [geoa]
plasma concentration [qnco]
Curve [spco]
Zero [qnco]
24 hours [tmco]
AUC [qnco]
Maximum [qnco]
Cmax [qnco]
Minimum [qlco]
Cmin [qnco]
Average [qnco]
drug concentration [qnco]
Reach [orgf]
Cmax [qnco]
Tmax [qnco]
Inspection [ftcn]
TOLERABILITY [resa]
Evaluated [ftcn]
Physical Examination [hlca]
Clinical measurements [hlca]
Laboratory [mnob, orgt]
adverse events [fndg]
Monitoring [hlca]
gabapentin [orch, phsu]
Exposure NOS [inpo]
steady state [npop]
Measured [qlco]
AUC [qnco]
Increased [qnco]
Doses [qnco]
mg day [qnco]
mg day [qnco]
Slight [qlco]
Decrease [qlco]
gabapentin [orch, phsu]
Relative [famg]
Bioavailability [qnco]
Increasing [ftcn]
Dose [qnco]
Compared [acty]
mg% [qnco]
Dose [qnco]
Relative [famg]
Bioavailability [qnco]
Compared [acty]
mg% [qnco]
Dose [qnco]
mg day [qnco]
Doses [qnco]
mg day [qnco]
Dose [qnco]
mg day [qnco]
Dose [qnco]
mg day [qnco]
Dose [qnco]
Cmax [qnco]
Increased [qnco]
Increasing [ftcn]
Dose [qnco]
Cmin [qnco]
Various [irda]
Treatments [topp]
Consistent [idcn]
Dose Regimen [topp]
Values [qlco]
Tmax [qnco]
Various [irda]
Doses [qnco]
Tmax [qnco]
Values [qlco]
Relative [famg]
Most Recent [tmco]
Dose [qnco]
Range [qnco]
8 Hours [tmco]
Dose Level [qnco]
gabapentin [orch, phsu]
Well [qlco]
Doses [qnco]
Study [mnob]
AES [gngm]
Headache [sosy]
Dizziness [sosy]
somnolence [fndg]
Mild [qlco]
Intensity [qlco]
Seven [qnco]
Patients [podg]
Withdraw [acty]
Study [mnob]
AES [gngm]
PHARMACOKINETIC [resa]
Profile [lbpr]
gabapentin [orch, phsu]
Twice daily [tmco]
Maintain [acty]
Bioavailability [qnco]
Efficacy [qlco]
gabapentin [orch, phsu]
Well [qlco]
